Zotefoams PLC
16 July 2026
Zotefoams plc
(the 'Company')
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMR
16 July 2026
The Company has received notification from MUFG Corporate Markets Trustees (UK) Limited, the Trustee of the Company's Share Incentive Plan (the 'SIP'), that on 13 July 2026 the following Director and Person Discharging Managerial Responsibilities became beneficially interested in the number of ordinary shares of 5 pence each in the Company under the SIP as detailed below. 'Partnership shares' were purchased at a price of £4.45 per share.
The table sets out both the number of partnership shares purchased and the number of matching shares that were allocated for nil consideration.
|
Director/PDMR |
Number of partnership shares purchased |
Number. of matching shares allocated
|
|
R M Cox |
34 |
8 |
|
N Wright |
34 |
9 |
The Notification of Dealing Form can be found below.
This announcement is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
Emma Woollard
Company Secretary
Zotefoams plc
020 8051 2770
Enquiries:
|
Zotefoams plc |
IFC Advisory (Financial PR & IR) |
|
Ronan Cox, Group CEO Nick Wright, Group CFO +44 (0) 208 664 1600 |
Graham Herring Tim Metcalfe Zach Cohen +44 (0) 203 934 6630 |
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in high-performance foam technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets.
Zotefoams is headquartered in London, UK, with manufacturing sites in Croydon, UK, Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Anglesola and Burgos, Spain (foam manufacture) and Jiangsu Province, China (T-FIT).
AZOTE®, ZOTEK®, and T-FIT® are registered trademarks of Zotefoams plc
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name: Ronan Michael Cox |
||||
2. |
Reason for the notification |
||||
|
a) |
Position/status: Group CEO |
||||
|
b) |
Initial notification/Amendment: Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name: Zotefoams plc |
||||
|
b) |
LEI: 213800B6P256B5XN8D32 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||
|
b) |
Nature of the transaction: Award of matching shares under the Company's Share Incentive Plan |
||||
|
c) |
Price(s) and volume(s):
|
||||
|
d) |
Aggregated information: n/a - single transaction |
||||
|
e) |
Date of the transaction: 13 July 2026 |
||||
|
f) |
Place of the transaction: XLON |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||
|
b) |
Nature of the transaction: Purchase of partnership shares under the Company's Share Incentive Plan |
||||
|
c) |
Price(s) and volume(s):
|
||||
|
d) |
Aggregated information: n/a - single transaction |
||||
|
e) |
Date of the transaction: 13 July 2026 |
||||
|
f) |
Place of the transaction: XLON |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name: Nick Wright |
||||
2. |
Reason for the notification |
||||
|
a) |
Position/status: Group CFO |
||||
|
b) |
Initial notification/Amendment: Initial notification |
||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name: Zotefoams plc |
||||
|
b) |
LEI: 213800B6P256B5XN8D32 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||
|
b) |
Nature of the transaction: Award of matching shares under the Company's Share Incentive Plan |
||||
|
c) |
Price(s) and volume(s):
|
||||
|
d) |
Aggregated information: n/a - single transaction |
||||
|
e) |
Date of the transaction: 11 June 2026 |
||||
|
f) |
Place of the transaction: XLON |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 |
||||
|
b) |
Nature of the transaction: Purchase of partnership shares under the Company's Share Incentive Plan |
||||
|
c) |
Price(s) and volume(s):
|
||||
|
d) |
Aggregated information: n/a - single transaction |
||||
|
e) |
Date of the transaction: 13 July 2026 |
||||
|
f) |
Place of the transaction: XLON |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.